Cargando…

Targeted Therapy After Brain Radiotherapy for BRAF-Mutated Melanoma With Extensive Ependymal Disease With Prolonged Survival: Case Report and Review of the Literature

Melanoma brain metastasis with ependymal spread/metastases is uncommon. These cases are frequently classified together with leptomeningeal disease. However, the commonalities and differences in the underlying pathophysiology and clinical outcomes between these two types of spread are not clear. Very...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abu-Gheida, Ibrahim, Chao, Samuel, Murphy, Erin, Suh, John, Stevens, Glen H., Mohammadi, Alireza M., McNamara, Michael, Yu, Jennifer S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443873/ https://www.ncbi.nlm.nih.gov/pubmed/30972290 http://dx.doi.org/10.3389/fonc.2019.00168

Ejemplares similares

Intermittent BRAF Inhibition Can Achieve Prolonged Disease Control in BRAF Mutant Melanoma
por: Jain, Tania, et al.
Publicado: (2015)

THER-10. IMPACT OF BRAF MUTATIONAL STATUS ON THE EFFICACY OF IMMUNOTHERAPY FOR MELANOMA BRAIN METASTASES
por: Lauko, Adam, et al.
Publicado: (2019)

THER-13. IMMUNOTHERAPY VERSUS STANDARD OF CARE IN MELANOMA BRAIN METASTASES WITH KNOWN BRAF STATUS
por: Barnett, Addison, et al.
Publicado: (2019)

Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma
por: Rossi, Ernesto, et al.
Publicado: (2019)

Case Report: Dynamic overlap of melanoma, sarcoidosis, and targeted therapy for BRAF-mutant melanoma
por: Dar, Nakul, et al.
Publicado: (2023)

Comparison of responses of human melanoma cell lines to MEK and BRAF inhibitors
por: Stones, Clare J., et al.
Publicado: (2013)

Phosphoproteomic Analysis of Cell-Based Resistance to BRAF Inhibitor Therapy in Melanoma
por: Parker, Robert, et al.
Publicado: (2015)

Inhibitors of pan-PI3K Signaling Synergize with BRAF or MEK Inhibitors to Prevent BRAF-Mutant Melanoma Cell Growth
por: Sweetlove, Melanie, et al.
Publicado: (2015)

Safety and Tolerability of BRAF Inhibitor and BRAF Inhibitor-Based Combination Therapy in Chinese Patients With Advanced Melanoma: A Real World Study
por: Liu, Xing, et al.
Publicado: (2021)

Diverse Mechanisms of BRAF Inhibitor Resistance in Melanoma Identified in Clinical and Preclinical Studies
por: Luebker, Stephen A., et al.
Publicado: (2019)

Kisspeptin-mediated improvement of sensitivity to BRAF inhibitors in vemurafenib-resistant melanoma cells
por: Guzzetti, Carlotta, et al.
Publicado: (2023)

Upright patient positioning for gantry-free breast radiotherapy: feasibility tests using a robotic chair and specialised bras
por: Boisbouvier, Sophie, et al.
Publicado: (2023)

Addressing the unmet needs of patients with BRAF-mutated melanoma in Latin America: Expert perspective
por: Salman, Pamela, et al.
Publicado: (2023)

Ependymal cells and neurodegenerative disease: outcomes of compromised ependymal barrier function
por: Nelles, Diana G, et al.
Publicado: (2022)

Treatment related toxicities with combination BRAF and MEK inhibitor therapy in resected stage III melanoma
por: Homan, Morgan, et al.
Publicado: (2022)

The Effect of Prolonged Duration of Intensity Modulated Radiotherapy for Nasopharyngeal Carcinoma
por: Hua, Yi-Jun, et al.
Publicado: (2021)

Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive BRAF Mutant Advanced Melanoma
por: Rossi, Ernesto, et al.
Publicado: (2023)

BRAF Mutation Is Associated with Improved Local Control of Melanoma Brain Metastases Treated with Gamma Knife Radiosurgery
por: Gallaher, Ian S., et al.
Publicado: (2016)

Ependymal enhancement on magnetic resonance imaging for the identification of high-grade gliomas
por: Waqas, Muhammad, et al.
Publicado: (2017)

Intracranial Control With Combination BRAF and MEK Inhibitor Therapy in Patients With Metastatic Melanoma
por: Hui, Caressa, et al.
Publicado: (2022)

Comparison Between First Line Target Therapy and Immunotherapy in Different Prognostic Categories of BRAF Mutant Metastatic Melanoma Patients: An Italian Melanoma Intergroup Study
por: Marconcini, Riccardo, et al.
Publicado: (2022)

Case Report: Rechallenge With BRAF and MEK Inhibitors in Metastatic Melanoma: A Further Therapeutic Option in Salvage Setting?
por: Stagno, Anna, et al.
Publicado: (2021)

Bilirubin Restrains the Anticancer Effect of Vemurafenib on BRAF-Mutant Melanoma Cells Through ERK-MNK1 Signaling
por: Tan, Yufan, et al.
Publicado: (2021)

THER-02. IMPACT OF SYSTEMIC THERAPY IN MELANOMA BRAIN METASTASIS
por: Sagar, Soumya, et al.
Publicado: (2019)

Clinical trial of carbon ion radiotherapy for gynecological melanoma
por: Karasawa, Kumiko, et al.
Publicado: (2014)

Classification and neuroimaging of ependymal tumors
por: Mu, Weiya, et al.
Publicado: (2023)

Ependymoma associated protein Zfta is expressed in immature ependymal cells but is not essential for ependymal development in mice
por: Herranz-Pérez, Vicente, et al.
Publicado: (2022)

Efficacy of BRAF Inhibitors in Combination With Stereotactic Radiosurgery for the Treatment of Melanoma Brain Metastases: A Systematic Review and Meta-Analysis
por: Khan, Muhammad, et al.
Publicado: (2021)

Prolonged Response Induced by Single Agent Vemurafenib in a BRAF V600E Spinal Ganglioglioma: A Case Report and Review of the Literature
por: Garnier, Louis, et al.
Publicado: (2019)

Systemic therapy augmented by radiotherapy (STAR) effect for brain metastases in a BRAF-mutated melanoma patient with prolonged survival: a case report
por: Cristaudo, Agostino, et al.
Publicado: (2021)

Utilization of Reactive Oxygen Species Targeted Therapy to Prolong the Efficacy of BRAF Inhibitors in Melanoma
por: Yuan, Long, et al.
Publicado: (2018)

Inhibition of melanoma using a nanoceria-based prolonged oxygen-generating phototherapy hydrogel
por: Zhang, Lidong, et al.
Publicado: (2023)

A Rare Complex BRAF Mutation Involving Codon V600 and K601 in Primary Cutaneous Melanoma: Case Report
por: Consoli, Francesca, et al.
Publicado: (2020)

Acceptability of Drugs in the Treatment of Unresectable/Metastatic BRAF V600-Mutant Melanoma: A Systematic Review and Network Meta-Analysis
por: Hong, Ling, et al.
Publicado: (2022)

Case Report: Delayed Onset Multi-Organ Toxicities in a Melanoma Patient Achieving Complete Response to BRAF/MEK Inhibition
por: Knochelmann, Hannah M., et al.
Publicado: (2022)

Intraoperative Radiation Therapy: A Promising Treatment Modality in Head and Neck Cancer
por: Hilal, Lara, et al.
Publicado: (2017)

Central Canal Ependymal Cells Proliferate Extensively in Response to Traumatic Spinal Cord Injury but Not Demyelinating Lesions
por: Lacroix, Steve, et al.
Publicado: (2014)

Ependymal Cyst Presenting with Lhermitte Sign
por: Franceschini, Paulo Roberto, et al.
Publicado: (2013)

Ependymal Cilia: Physiology and Role in Hydrocephalus
por: Ji, Weiye, et al.
Publicado: (2022)

A Rare Finding of a BRAF Mutation in Renal Cell Carcinoma with Response to BRAF-Directed Targeted Therapy
por: Banerjee, Natasha, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_d3squmm5cbm1pnndofemb9tef9